The oral drug, nilotinib, is used to treat chronic myeloid leukemia, and may be made in Egypt, Guatemala, Indonesia, Morocco, Pakistan, the Philippines and Tunisia.
The platform-integrated product eliminates the use of multiple tools, systems and processes and provides users with complete chain of custody tracking.
The deal with Chinese state-owned drug-maker Sinopharm to import and market its antiviral molnupiravir in China is a sign the country is considering more COVID-19 medicines from overseas developers.
Jim Cafone, a senior vice president of supply chain at Pfizer, says the rapid and successful rollout of the doses shows companies now will “need to really rethink how you configure your supply chain.”
President Joe Biden signed an executive order laying out a strategy to bolster domestic bio-manufacturing and reduce reliance on China for new medicines, chemicals and other products.
A report on current consumer perception and trust for high importance or time critical deliveries, such as medical devices and travel documents indicates there many opportunities to improve.
Bavarian Nordic A/S, the only company with an approved vaccine for monkeypox, said it’s no longer certain it can meet demand and is talking to multiple production partners as cases rise across the world.
The National Community Pharmacists Association surveyed store owners and managers about their experiences purchasing brand and generic Adderall between July 25 and Aug. 5. Of the 358 who responded, 64% said that the medicines were on back order, the group said.
The latest supply-chain news, analysis, trends and tools for executives in the pharmaceutical and biotech industries. Learn how pharmaceutical and biotech companies and their suppliers around the world are managing the flow of products across all channels of the enterprise. Experts sound off on forecasting and demand planning, supply-chain visibility, logistics outsourcing, inventory optimization, transportation management, warehouse management, supply-chain security, corporate social responsibility and more.
Subscribe to our Daily Newsletter!
Timely, incisive articles delivered directly to your inbox.